http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108285480-B
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57411 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-42 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-42 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 |
filingDate | 2018-02-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2021-02-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2021-02-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-108285480-B |
titleOfInvention | Dodecapeptide and application thereof in preparation of products for treating and/or diagnosing cervical cancer |
abstract | The invention relates to the technical field of medicines, in particular to dodecapeptide and application thereof in preparing products for treating and/or diagnosing cervical cancer. The invention provides a polypeptide of an amino acid sequence shown in any one of SEQ ID NO 1-3, and experiments prove that the polypeptide has a specific recognition effect on cervical cancer cells or tissues, so that the polypeptide can be used as a detection reagent of the cervical cancer cells or a diagnostic reagent of the cervical cancer, and can also be used as a carrier of a cervical cancer targeted therapeutic drug. The experiment of the invention shows that the polypeptide can only identify cervical cancer cells and has no identification effect on other tumor cells. |
priorityDate | 2018-02-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 74.